ABTB1 and colorectal carcinoma: For example, the decreased expression of miR-4319, as reported, is related to the poor prognosis of CRC patients, and miR-4319 significantly inhibits the proliferation of CRC cells and changes cell cycle distribution by targeting ABTB1 [23].